About

Tavotek is an innovative technology research and development company founded by senior scientists from top multinational pharmaceutical companies, focusing on the development of biologic therapeutics. Tavotek has a headquartered in Hong Kong, China and has a research and development laboratory in Pennsylvania, USA. The founding team members of the company have vast expertise in different fields with experience which covers key steps in the process of drug development from antibody engineering, drug efficacy evaluation to clinical development. Tavotek has established three technical platforms: antibody drug engineering platform, immunomodulation antibodies platform and an intracellular and extracellular biopharmaceutical platform. Tavotek biologic drugs are expected to meet broad clinical needs in the fields of immunotherapy, respiratory diseases and cardiovascular diseases.